[1]
|
Ahmad, A. (2019) Breast Cancer Statistics: Recent Trends. In: Ahmad, A., Ed., Breast Cancer Metastasis and Drug Resistance. Advances in Experimental Medicine and Biology, Vol. 1152, Springer, Cham, 1-7.
https://doi.org/10.1007/978-3-030-20301-6_1
|
[2]
|
Law, A.M.K., Fuente, L.R., Grundy, T.J., et al. (2021) Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies. Frontiers in Oncology, 11, Article 782766. https://doi.org/10.3389/fonc.2021.782766
|
[3]
|
Fröhlich, E. (2023) The Variety of 3D Breast Cancer Models for the Study of Tumor Physiology and Drug Screening. International Journal of Molecular Sciences, 24, Article No. 7116. https://doi.org/10.3390/ijms24087116
|
[4]
|
Sztankovics, D., Moldvai, D., Petővári, G., et al. (2023) 3D Bioprinting and the Revolution in Experimental Cancer Model Systems—A Review of Developing New Models and Experiences with in Vitro 3D Bioprinted Breast Cancer Tissue-Mimetic Structures. Pathology and Oncology Research, 29, Article ID: 1610996.
https://doi.org/10.3389/pore.2023.1610996
|
[5]
|
Santiago, L., Volk, R.J., Checka, C.M., et al. (2021) Acceptability of 3D-Printed Breast Models and Their Impact on the Decisional Conflict of Breast Cancer Patients: A Feasibility Study. Journal of Surgical Oncology, 123, 1206-1214.
https://doi.org/10.1002/jso.26420
|
[6]
|
Trivedi, P., Liu, R., Bi, H., et al. (2021) 3D Modeling of Epithelial Tumors—The Synergy between Materials Engineering, 3D Bioprinting, High-Content Imaging, and Nanotechnology. International Journal of Molecular Sciences, 22, Article No. 6225. https://doi.org/10.3390/ijms22126225
|
[7]
|
Roberts, S., Peyman, S. and Speirs, V. (2019) Current and Emerging 3D Models to Study Breast Cancer. In: Ahmad, A., Ed., Breast Cancer Metastasis and Drug Resistance. Advances in Experimental Medicine and Biology, Vol. 1152, Springer, Cham, 413-427. https://doi.org/10.1007/978-3-030-20301-6_22
|
[8]
|
Mittal, S., Brown, N.J. and Holen, I. (2018) The Breast Tumor Microenvironment: Role in Cancer Development, Progression and Response to Therapy. Expert Review of Molecular Diagnostics, 18, 227-243.
https://doi.org/10.1080/14737159.2018.1439382
|
[9]
|
李孟, 梁则徐, 李冠男, 等. 中医中药治疗乳腺癌的研究进展[J]. 中医药学报, 2023, 51(2): 103-108.
|
[10]
|
张梦秋, 高静东. 中医中药治疗乳腺癌临床进展分析[J]. 中西医结合心血管病电子杂志, 2020, 8(6): 30-31.
|
[11]
|
Jiang, H., Li, M., Du, K., et al. (2021) Traditional Chinese Medicine for Adjuvant Treatment of Breast Cancer: Taohong Siwu Decoction. Chinese Medicine, 16, Article No. 129. https://doi.org/10.1186/s13020-021-00539-7
|
[12]
|
Lu, Y., Ding, Y., Wei, J., et al. (2021) Anticancer Effects of Traditional Chinese Medicine on Epithelial-Mesenchymal Transition (EMT) in Breast Cancer: Cellular and Molecular Targets. European Journal of Pharmacology, 907, Article ID: 174275. https://doi.org/10.1016/j.ejphar.2021.174275
|
[13]
|
Yang, Z., Zhang, Q., Yu, L., et al. (2021) The Signaling Pathways and Targets of Traditional Chinese Medicine and Natural Medicine in Triple-Negative Breast Cancer. Journal of Ethnopharmacology, 264, Article ID: 113249.
https://doi.org/10.1016/j.jep.2020.113249
|
[14]
|
Sun, Y., Zhou, Q.-M., Lu, Y.-Y., et al. (2019) Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition. Molecules, 24, Article No. 1131. https://doi.org/10.3390/molecules24061131
|
[15]
|
王真, 陈立伟. 白藜芦醇抗肿瘤药理作用机制研究进展.药物评价研究, 2023, 46(2): 445-451.
|
[16]
|
Wang, K., Chen, Q., Shao, Y., et al. (2021) Anticancer Activities of TCM and Their Active Components against Tumor Metastasis. Biomed Pharmacother, 133, Article ID: 111044. https://doi.org/10.1016/j.biopha.2020.111044
|
[17]
|
闵思丹, 王宇. 华蟾素在抗肿瘤作用机制中的研究进展[J]. 中医药学报, 2022, 50(11): 96-101.
|
[18]
|
Zhu, L., Chen, Y., Wei, C., et al. (2018) Anti-Proliferative and Pro-Apoptotic Effects of Cinobufagin on Human Breast Cancer MCF-7 Cells and Its Molecular Mechanism. Natural Product Research, 32, 493-497.
https://doi.org/10.1080/14786419.2017.1315575
|
[19]
|
Bhuskute, H., Shende, P. and Prabhakar, B. (2021) 3d Printed Personalized Medicine for Cancer: Applications for Betterment of Diagnosis, Prognosis and Treatment. AAPS PharmSciTech, 23, Article No. 8.
https://doi.org/10.1208/s12249-021-02153-0
|
[20]
|
Cheung, Y.T., Lee, H.H. and Chan, A. (2013) Exploring Clinical Determinants and Anxiety Symptom Domains among Asian Breast Cancer Patients. Supportive Care in Cancer, 21, 2185-2194. https://doi.org/10.1007/s00520-013-1769-8
|
[21]
|
Phi, X.A., Tagliafico, A., Houssami, N., et al. (2018) Digital Breast Tomosynthesis for Breast Cancer Screening and Diagnosis in Women with Dense Breasts—A Systematic Review and Meta-Analysis. BMC Cancer, 18, Article No. 380. https://doi.org/10.1186/s12885-018-4263-3
|
[22]
|
Furuta, S. and Bissell, M.J. (2016) Pathways Involved in Formation of Mammary Organoid Architecture Have Keys to Understanding Drug Resistance and to Discovery of Druggable Targets. Cold Spring Harbor Symposia on Quantitative Biology, 81, 207-217. https://doi.org/10.1101/sqb.2016.81.030825
|
[23]
|
Langer, E.M., Allen-Petersen, B.L., King, S.M., et al. (2019) Modeling Tumor Phenotypes in Vitro with Three-Di- mensional Bioprinting. Cell Reports, 26, 608-623. https://doi.org/10.1016/j.celrep.2018.12.090
|
[24]
|
Swaminathan, S., Hamid, Q., Sun, W., et al. (2019) Bioprinting of 3d Breast Epithelial Spheroids for Human Cancer Models. Biofabrication, 11, Article ID: 025003. https://doi.org/10.1088/1758-5090/aafc49
|
[25]
|
Souza, A.G., Silva, I.B.B., Campos-Fernandez, E., et al. (2018) Comparative Assay of 2D and 3D Cell Culture Models: Proliferation, Gene Expression and Anticancer Drug Response. Current Pharmaceutical Design, 24, 1689-1694.
https://doi.org/10.2174/1381612824666180404152304
|
[26]
|
关冀弛, 刘丹, 陈艳阁, 等. 肿瘤细胞三维培养技术研究进展[J]. 沈阳医学院学报, 2022, 24(6): 641-647.
|
[27]
|
Hoarau-Véchot, J., Rafii, A., Touboul, C. and Pasquier, J. (2018) Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions? International Journal of Molecular Sciences, 19, Article No. 181. https://doi.org/10.3390/ijms19010181
|
[28]
|
Li, Y. and Kilian, K.A. (2015) Bridging the Gap: From 2D Cell Culture to 3D Microengineered Extracellular Matrices. Advanced Healthcare Materials, 4, 2780-2796. https://doi.org/10.1002/adhm.201500427
|
[29]
|
Bahcecioglu, G., Basara, G., Ellis, B.W., Ren, X. and Zorlutuna, P. (2020) Breast Cancer Models: Engineering the Tumor Microenvironment. Acta Biomaterialia, 106, 1-21. https://doi.org/10.1016/j.actbio.2020.02.006
|
[30]
|
Lazzari, G., Nicolas, V., Matsusaki, M., et al. (2018) Multicellular Spheroid Based on a Triple CO-Culture: A Novel 3D Model to Mimic Pancreatic Tumor Complexity. Acta Biomaterialia, 78, 296-307.
https://doi.org/10.1016/j.actbio.2018.08.008
|
[31]
|
Tomás-Bort, E., Kieler, M., Sharma, S., et al. (2020) 3D Approaches to Model the Tumor Microenvironment of Pancreatic Cancer. Theranostics, 10, 5074-5089. https://doi.org/10.7150/thno.42441
|
[32]
|
Sharifi, M., Bai, Q., Babadaei, M.M.N., et al. (2021) 3D Bioprinting of Engineered Breast Cancer Constructs for Personalized and Targeted Cancer Therapy. Journal of Controlled Release, 333, 91-106.
https://doi.org/10.1016/j.jconrel.2021.03.026
|
[33]
|
Germain, N., Dhayer, M., Dekiouk, S. and Marchetti, P. (2022) Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine. International Journal of Molecular Sciences, 23, Article No. 3432.
https://doi.org/10.3390/ijms23073432
|
[34]
|
Tiwari, A.P., Thorat, N.D., Pricl, S., et al. (2021) Bioink: A 3D-Bioprinting Tool for Anticancer Drug Discovery and Cancer Management. Drug Discovery Today, 26, 1574-1590. https://doi.org/10.1016/j.drudis.2021.03.010
|
[35]
|
Kang, Y., Datta, P., Shanmughapriya, S. and Ozbolat, I.T. (2020) 3D Bioprinting of Tumor Models for Cancer Research. ACS Applied Bio Materials, 3, 5552-5573. https://doi.org/10.1021/acsabm.0c00791
|
[36]
|
Kronemberger, G.S., Miranda, G.A.S.C., Tavares, R.S.N., et al. (2021) Recapitulating Tumorigenesis in Vitro: Opportunities and Challenges of 3D Bioprinting. Frontiers in Bioengineering and Biotechnology, 9, Article 682498.
https://doi.org/10.3389/fbioe.2021.682498
|
[37]
|
Qi, F., Zhao, L., Zhou, A., et al. (2015) The Advantages of Using Traditional Chinese Medicine as an Adjunctive Therapy in the Whole Course of Cancer Treatment Instead of Only Terminal Stage of Cancer. BioScience Trends, 9, 16-34. https://doi.org/10.5582/bst.2015.01019
|
[38]
|
吕威, 李帅杰, 严青, 等. 乳腺癌术后中西医结合治疗的研究进展[J]. 中国当代医药, 2022, 29(33): 28-31, 37.
|
[39]
|
Liu, Y., Yang, S., Wang, K., et al. (2020) Cellular Senescence and Cancer: Focusing on Traditional Chinese Medicine and Natural Products. Cell Proliferation, 53, e12894. https://doi.org/10.1111/cpr.12894
|